Menu

 

Research News

Denosumab may reduce hypercalcaemia after transplantation for osteopetrosis

BMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e7477 (Published 7 November 2012)
Cite this as: BMJ 2012;345:e7477

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

N Engl J Med2012; doi:10.1056/NEJMc1206193

In osteopetrosis, defective osteoclasts impair bone resorption and excessive bone is formed. Haematopoietic stem cell transplantation is the only cure for this rare inherited disorder, but it is …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Subscribe

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

Latest comments and most commented

THIS WEEK'S POLL

Read related article

See previous polls